EODData

MEMBERSHIP REGISTER LOG IN

OTCBB, PPTDF: Peptidream Inc

09 Jan 2026
LAST:

11.00

CHANGE:
 0.75		OPEN:
11.00		HIGH:
11.00		ASK:
0.00		VOLUME:
100
CHG(%):
6.38		PREV:
11.75		LOW:
11.00		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
09 Jan 2611.0011.0011.0011.00100
08 Jan 2612.0012.0011.7511.751.2K
06 Jan 2612.3912.3912.3912.39100
31 Dec 2512.4812.4812.4812.48100
30 Dec 2511.4211.4211.4211.42100

PROFILE

Name:Peptidream Inc
About:PeptiDream Inc., a biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics. The company develops its products based on its Peptide Discovery Platform System, a drug finding platform that enables the production of non-standard peptide libraries for the identification of potent and selective macrocyclic peptide candidates, which then can be developed into peptide-based, small molecule-based, peptide-drug conjugate, and multi-functional peptide conjugates -based therapeutics and diagnostics. Its development pipeline include PD-L1 indicated for oncology and currently under Ph1 clinical phase development stage; PD-L1 BMS-986229 indicated for oncology and currently under Ph1 clinical phase development stage; CD38 BHV-1100 + NK Cells indicated for multiple myeloma and currently under Ph1 clinical phase development stage; S2-protein PA-001 indicated for COVID-19 and currently under Ph1 clinical phase development stage; GhR AZP-3813 indicated for acromegaly/NET and currently under Ph1 clinical phase development stage; Glypican-3 indicated for liver cancer and currently under preclinical development stage; Myostatin indicated for DMD/muscle disorders and currently under preclinical development stage; TfR indicated for neuromuscular disorders and currently under preclinical development stage; c-Kit indicated for allergic condition and currently under preclinical development stage; c-Met currently under preclinical development stage; and HA-protein indicated for influenza and currently under preclinical development stage. It also involved in the research, development, manufacture, sale, export, and import of various radiopharmaceutical and radio diagnostic products. It has a collaboration with Novartis Pharma AG. PeptiDream Inc. was incorporated in 2006 and is based in Kawasaki, Japan.
Sector:Healthcare
Industry:Biotechnology
Address:3-25-23 Tonomachi, Kawasaki, Japan, 210-0821
Website:https://www.peptidream.com
FIGI:BBG006Z5JGB8

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:11.817.3%
MA10:11.666.0%
MA20:11.292.7%
STO9:2.89 
STO14:42.90
RSI14:50.00
WPR14:-56.43
MTM14:-0.81
ROC14:-0.07 
ATR:0.73 
Week High:12.3912.6%
Week Low:11.000.0%
Month High:12.8516.8%
Month Low:11.00
Volatility:7.53